Sweden is traditionally a great place to start a wound care company. Several established global leaders are based there, like Mölnlycke*, Essity* and Arjo*. They fund early-stage companies and act as a source of skilled personnel. Strong universities and leading pharma and medical device companies also contribute to a dynamic market.
In the fall of 2023, not one, not two, but three Swedish companies found themselves in deep trouble. RLS Global filed for bankruptcy, Promore Pharma was liquidated and S2Medical was under reconstruction. In this article, SmartTRAK looks deeper at those companies, what went wrong, and highlights a few startups embarking on the journey. Lessons learned are not limited to the Swedish market but apply everywhere.
The companies covered in detail in this comprehensive Market Perspective article, which can be downloaded in its entirety here, are:
Although the fall of 2023 was challenging for a few companies, the future looks bright for Sweden to maintain its position as a strong generator of ...
* These links can only be accessed by SmartTRAK subscribers. To learn more about SmartTRAK and how to subscribe, scroll down.
To download and read the complete "Swedish Wound Care Companies – You Win Some, You Lose Some" Market Perspective article by Lennart Stadler, GM Consulting & OUS Content, just click the button below.